Spain · Advertising framework
Print advertising and advertorials for diagnostic tests and services in Spain
General market orientation, not campaign clearance. Research scope and dates
Product and service rules
Check professional-use and publicly funded product restrictions
Legal requirement — paraphrased
Applies when: The product falls within the relevant Spanish health-product provisions, including a separate IVD assessment where appropriate.
Article 80 restricts public advertising of health products financed by the national health system and products intended exclusively for healthcare professionals. Check the precise product definition, the applicable device or IVD framework and regional advertising controls; a CE mark alone is insufficient to determine public-ad eligibility.
Sources: RDL 1/2015: guarantees and rational use of medicines and health products; Real Decreto 192/2023 on medical devices
Separate diagnostic products from diagnostic services
Legal requirement — paraphrased
IVDR Article 7 prohibits misleading claims for an in vitro diagnostic device. Describe the intended purpose, users and limitations consistently with its conformity documentation. An advertisement for a laboratory consultation also needs the applicable local provider review; the IVDR does not by itself authorise a medical service.
Sources: EU In Vitro Diagnostic Medical Devices Regulation 2017/746
Apply the expressly retained IVD advertising rules
Legal requirement — paraphrased
RD 942/2025 retains articles 25 and 27 of RD 1662/2000 pending specific replacement legislation. Article 25 requires prior autonomous-community approval for eligible public IVD advertising and disclosure of accuracy and limitations. It prohibits public genetic-test advertising and public self-test advertising except pregnancy, fertility, HIV and COVID-19 self-tests. A product sale exemption is not automatically an advertising exemption.
Sources: Royal Decree 942/2025 — IVD transition; Royal Decree 1662/2000 — retained advertising provisions
Channel rules
Check the complete consumer-facing message
Regulator guidance
The EU consumer-protection framework addresses misleading actions and omissions, including an overall deceptive presentation and undisclosed commercial intent. Review benefits, risks, qualifications and prices as a whole under the national implementing law. Space limits do not provide an automatic exemption from material information requirements.
Sources: EU Unfair Commercial Practices Directive 2005/29/EC
Review at final printed size
Editorial recommendation
Approve the advertorial label, full layout and legibility at actual size. Check what must appear in the advertisement itself before moving details behind a QR code.
Campaign workflow
Diagnostics & Health Testing: prepare the review
Editorial recommendation
Separate a test kit, laboratory service, screening package and medical interpretation. State the intended population and explain the limits of a positive or negative result. Review both product rules and provider rules when a device is bundled with a clinical service.
Keep a traceable campaign decision
Editorial recommendation
Keep one review record linking the offer, local market status, claim evidence, exact creative, media settings and any regulatory or professional clearance. Record who checked each condition. Reopen the review when the offer, claim, source rule or execution changes.
Pre-publication checklist
- Separate a test kit, laboratory service, screening package and medical interpretation.
- State the intended population and explain the limits of a positive or negative result.
- Review both product rules and provider rules when a device is bundled with a clinical service.
- Record product or provider eligibility before approving claims.
- Archive the final creative and its evidence, permissions and review decisions.
- Assign an owner for source updates, complaints and prompt withdrawal of inaccurate material.
Scope and unresolved questions
- Retained IVD advertising rules, Madrid device-ad approval and provider registration-number requirements are documented. Determine the actual autonomous community before filing; other regional procedures, profession-specific codes and the exact promotion remain to be checked.
- This national baseline does not review every broadcaster rule, platform policy, regional licensing condition, promotion mechanic or data-transfer arrangement. No format-specific warning dimensions or durations should be inferred where none are supplied.
Research scope, introduction and dates
Advertising diagnostic tests and services in print campaigns in Spain requires a distinction between the test product, the laboratory service and the interpretation of the result. Use this framework to review those layers and the limits of the advertised outcome.
Printed advertisements must work at their final physical size. Review the advertorial label, required information, images and multipage layout together, including what stays on the page when a QR code points readers elsewhere.
General market orientation, not legal, regulatory or medical advice, a complete compliance plan or clearance of an advertisement. Actual requirements depend on the specific offer and campaign.
How to use this national baseline
Editorial overview
This framework combines researched national rules with editorial review steps. Spanish national health-advertising baseline plus EU requirements; autonomous-community rules remain relevant. A visible channel workflow does not establish that the selected product or service may be advertised there. Read the category restrictions first.
The review date identifies when the cited provisions or regulator excerpts were checked. It does not mean that every local rule, exception, professional standard or platform policy has been reviewed.
Sources
- RDL 1/2015: guarantees and rational use of medicines and health products
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- Real Decreto 192/2023 on medical devices
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- EU In Vitro Diagnostic Medical Devices Regulation 2017/746
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- EU Unfair Commercial Practices Directive 2005/29/EC
EU framework implemented through national law; sector rules and local implementation also apply.
- Royal Decree 942/2025 — IVD transition
Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.
- Royal Decree 1662/2000 — retained advertising provisions
Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.
From framework to action
Local expertise in Spain
Find support with medical and health marketing, marketing and sales advice, or organizing your business and coordinating projects in Spain.
Medical & health marketing
No partners listed in this category yet.
Marketing & sales advisory
No partners listed in this category yet.
Business & project coordination
No partners listed in this category yet.
Join the local partner directory
Would you like your company to be listed?
Talk to us about the terms of a listing. Leave your details and we will get in touch.